{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:15:14Z","timestamp":1786119314196,"version":"build-2736575974"},"reference-count":13,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,10]]},"DOI":"10.1097\/mph.0b013e3181b530ad","type":"journal-article","created":{"date-parts":[[2009,9,26]],"date-time":"2009-09-26T03:15:15Z","timestamp":1253934915000},"page":"787-789","source":"Crossref","is-referenced-by-count":17,"title":["Low Dose Vincristine-induced Severe Polyneuropathy in a Hodgkin Lymphoma Patient"],"prefix":"10.1097","volume":"31","author":[{"given":"Timucin","family":"Cil","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdullah","family":"Altintas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusuf","family":"Tamam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esra","family":"Battalo\u011flu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdurrahman","family":"Isikdogan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-22-20210227","first-page":"681","article-title":"Peripheral neurotoxic disorders","volume":"18","author":"Bromberg","year":"2000","journal-title":"Clin Neurobehav Toxicol"},{"key":"R2-22-20210227","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1042\/cs038023Pb","article-title":"Vincristine neurotoxicity: a clinical and electrophysiological study of eighteen patients","volume":"38","author":"Casey","year":"1970","journal-title":"Clin Sci"},{"key":"R3-22-20210227","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1093\/brain\/96.1.69","article-title":"Vincristine neuropathy. Clinical and electrophysiological observations","volume":"96","author":"Casey","year":"1973","journal-title":"Brain"},{"key":"R4-22-20210227","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1023\/A:1008369315240","article-title":"Acute deterioration of Charcot-Marie Tooth disease IA (CMT IA) following 2\u2009mg of vincristine chemotherapy","volume":"11","author":"Hildebrandt","year":"2000","journal-title":"Ann Oncol"},{"key":"R5-22-20210227","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1002\/mpo.2950250212","article-title":"Vincristine neuropathy in type I and type II Charcot-Marie-Tooth disease (hereditary motor sensory neuropathy)","volume":"25","author":"Igarashi","year":"1995","journal-title":"Med Pediatr Oncol"},{"key":"R6-22-20210227","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0733-8619(18)30825-9","article-title":"Hereditary motor-sensory neuropathies. Charcot-Marie-Tooth syndrome","volume":"7","author":"Bird","year":"1989","journal-title":"Neurol Clin"},{"key":"R7-22-20210227","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1097\/00043426-200304000-00010","article-title":"Vincristine-induced neuropathy as the initial presentation of CMT disease in acute lymphoblastic leukemia: A Pediatric Oncology Group Study","volume":"25","author":"Chauvenet Allen","year":"2003","journal-title":"J Hametol Oncol"},{"key":"R8-22-20210227","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1002\/mus.880180302","article-title":"Charcot-Marie-Tooth neuropathies: from clinical description to molecular genetics","volume":"18","author":"Ionasescu","year":"1995","journal-title":"Muscle Nerve"},{"key":"R9-22-20210227","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/0092-8674(91)90613-4","article-title":"DNA duplication associated with Charcot-Marie-Tooth disease type IA","volume":"66","author":"Lupski","year":"1991","journal-title":"Cell"},{"key":"R10-22-20210227","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1136\/jnnp.58.5.523","article-title":"Myelin gene dosage and mutation in the hereditary motor and sensory neuropathies: a review","volume":"58","author":"Nicholson","year":"1995","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"R11-22-20210227","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.jns.2005.11.014","article-title":"Medication-induced exacerbation of in CMT Disease","volume":"242","author":"Weimer","year":"2006","journal-title":"J Neurol Sci"},{"key":"R12-22-20210227","doi-asserted-by":"crossref","first-page":"2862","DOI":"10.1001\/jama.1984.03350200048021","article-title":"Poly-neuropathy following vincristine therapy in two patients with Charcot-Marie-Tooth syndrome","volume":"252","author":"Hogan-Dann","year":"1984","journal-title":"JAMA"},{"key":"R13-22-20210227","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1046\/j.1365-2141.2001.03126.x","article-title":"Early recognition of hereditary motor and sensory neuropathy type 1 can avoid life-threatening vincristine neurotoxicity","volume":"115","author":"Naumann","year":"2001","journal-title":"Br J Haematol"}],"container-title":["Journal of Pediatric Hematology\/Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MPH.0b013e3181b530ad","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T18:01:44Z","timestamp":1786039304000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00043426-200910000-00022"}},"subtitle":["A Case Report (Vincristine-induced Severe Polyneuropathy)"],"short-title":[],"issued":{"date-parts":[[2009,10]]},"references-count":13,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2009]]}},"URL":"https:\/\/doi.org\/10.1097\/mph.0b013e3181b530ad","relation":{},"ISSN":["1077-4114"],"issn-type":[{"value":"1077-4114","type":"print"}],"subject":[],"published":{"date-parts":[[2009,10]]}}}